Integrating best practices in AI, genomics, cell culture, and laboratory techniques together contribute to protein expression success.

IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Phase 3 Ovarian Cancer Trial to Initiate in March 2025 Imunon, Inc. (NASDAQ:IMNN) is continuing preparations to conduct a Phase 3 clinical trial ...

Beyond manufacturing capacity, sponsors seek expertise in specialized drug formulations, regulatory affairs, and service ...

Perovskite solar cells are poised to be the next big photovoltaic ... This study shows that perovskites can be recovered efficiently and cost-effectively using a relatively simple method, says ...

The rise in cell therapy research and development, coupled with increasing ... which contribute to the efficient and cost-effective production of cell therapies. While the potential of cell ...

"They may ultimately determine that a decryption tool is their best option and negotiate to reduce the final payment, but more often, they find that restoring from recent backups is the faster and ...

Andrew Stanton is a Newsweek weekend reporter based in Maine. His role is reporting on U.S. politics and social issues. Andrew joined Newsweek in 2021 from The Boston Globe. He is a graduate of ...